Monoclonal and polyclonal antibodies in lung and muscle development have recently been made available from Seven Hills Bioreagents (SHB), a venture of Cincinnati Children's Research Foundation (CCRF), directly from its web site.
SHB claims that, because the reagents available from SHB are supplied by expert researchers who are actively using them in their own laboratories, SHB is able to provide unprecedented product support.
Dr. Clarissa Naftzger, an immunologist with extensive background in biotechnology, was hired in 2003 to spearhead this initiative.
"This is a novel initiative for our research institution that should directly benefit research programs at Cincinnati Children's Hospital while providing valuable tools to scientists throughout the world," Naftzger said.
"Many of the antibodies we’re now supplying directly have been sold through third parties for years," she added.
Additionally, a Scientific Advisory Board composed of leading scientists in the Cincinnati medical research community is providing guidance on the development of new products.
"This new enterprise is an alternative commercial strategy to traditional licensing agreements," said Joseph Fondacaro, Ph.D., Director of CCRF’s Office of Intellectual Property.